Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Isabel Schemainda"'
Autor:
Isabel Schemainda, Yuchun Chen, Cornelia Matei, Leonard B. Saltz, Alan A. Alfieri, Manickam Muruganandham, Max Hasmann, Jason A. Koutcher, George Sukenick
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 11(9)
Purpose: Attempts to selectively initiate tumor cell death through inducible apoptotic pathways are increasingly being exploited as a potential anticancer strategy. Inhibition of NAD+ synthesis by a novel agent FK866 has been recently reported to ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55cc7094837527dda28c4045c5837fe5
https://pubmed.ncbi.nlm.nih.gov/15867253
https://pubmed.ncbi.nlm.nih.gov/15867253
Autor:
Max, Hasmann, Isabel, Schemainda
Publikováno v:
Cancer research. 63(21)
Deregulation of apoptosis, the physiological form of cell death, is closely associated with immunological diseases and cancer. Apoptosis is activated either by death receptor-driven or mitochondrial pathways, both of which may provide potential targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::beb80a7b6aa030fcc8b621b8cdb733c3
https://pubmed.ncbi.nlm.nih.gov/14612543
https://pubmed.ncbi.nlm.nih.gov/14612543
Autor:
Katja, Wosikowski, Karin, Mattern, Isabel, Schemainda, Max, Hasmann, Benno, Rattel, Roland, Löser
Publikováno v:
Cancer research. 62(4)
We recently developed a class of novel antitumor agents that elicit a potent growth-inhibitory response in many tumor cells cultured in vitro. WK175, a member of this class, was chosen as a model compound that showed strong in vitro efficacy. WK175 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de678bcac9c47cde448b34b1b0a655fb
https://pubmed.ncbi.nlm.nih.gov/11861382
https://pubmed.ncbi.nlm.nih.gov/11861382